Patent ID: 7468361

Claim:
A method of treating skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion which comprises administering to a subject an effective amount of a compound selected from the group consisting of: 19-nor-2α-ethyl-1α,25-dihydroxyvitamin D3, 19-nor-2β-ethyl-1α,25-dihydroxyvitamin D3, 19-nor-20(S)-2α-ethyl-1α,25-dihydroxyvitamin D3, 19-nor-20(S)-2β-ethyl-1α,25-dihydroxyvitamin D3, 19-nor-2(E)-ethylidene-1α,25-dihydroxyvitamin D3, 19-nor-2(Z)-ethylidene-1α,25-dihydroxyvitamin D3, 19-nor-2(E)-ethylidene-20(S)-1α,25-dihydroxyvitamin D3, and 19-nor-2(Z)-ethylidene-20(S)-1α,25-dihydroxyvitamin D 3 .